US Patent Issued to Biolitec Unternehmensbeteiligungs II on Sept. 2 for "Specifically meso-substituted porphyrins and chlorins for photodynamic therapy" (German Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,127, issued on Sept. 2, was assigned to Biolitec Unternehmensbeteiligungs II AG (Vienna).

"Specifically meso-substituted porphyrins and chlorins for photodynamic therapy" was invented by Hartwig Richard Arthur Golf (Berlin), Arno Wiehe (Berlin), Susanna Graefe (Jena, Germany), Volker Albrecht (Nuthetal, Germany) and Hans-Ulrich ReiBig (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "Biologically active compounds that can be used as photosensitizers for diagnostic and therapeutic applications, particularly for PDT of cancer, infections and other hyperproliferative diseases, fluorescence diagnosis and PDT treatment of a non-tumorous indication s...